Insulin Aspart (Vials) and Skyrizi (150 MG Dose)
Determining the interaction of Insulin Aspart (Vials) and Skyrizi (150 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Skyrizi, Skyrizi topical
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart (Vials)-Skyrizi Injection
- Insulin Aspart (Vials)-Skyrizi topical
- Insulin Aspart (Vials)-Sleep Aid
- Insulin Aspart (Vials)-Sleep Aid Tablets
- Insulin Aspart (Vials)-Sleepinal
- Insulin Aspart (Vials)-Slo-Niacin
- Skyrizi (150 MG Dose)-Insulin Aspart (Vials) (Fiasp)
- Skyrizi (150 MG Dose)-Insulin aspart and insulin aspart protamine
- Skyrizi (150 MG Dose)-Insulin aspart and insulin degludec Subcutaneous
- Skyrizi (150 MG Dose)-Insulin Aspart Injection
- Skyrizi (150 MG Dose)-Insulin Aspart Protamine and Insulin Aspart
- Skyrizi (150 MG Dose)-Insulin aspart protamine and insulin aspart Subcutaneous